Cleveland BioLabs
CBLI
#9801
Rank
NZ$84.93 M
Marketcap
NZ$5.49
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Earnings for Cleveland BioLabs (CBLI)

Earnings in 2021 (TTM): -NZ$3.97 Million

According to Cleveland BioLabs 's latest financial reports the company's current earnings are NZ$0.63 Million. In 2020 the company made an earning of -NZ$4.45 Million a decrease over its 2019 earnings that were of -NZ$4.09 Million.

Earnings history for Cleveland BioLabs from 2004 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-NZ$3.97 Million-10.87%
2020-NZ$4.45 Million8.8%
2019-NZ$4.09 Million-50.81%
2018-NZ$8.31 Million-14.3%
2017-NZ$9.7 Million-11.88%
2016-NZ$11.01 Million-50.9%
2015-NZ$22.41 Million-10.24%
2014-NZ$24.97 Million-37.5%
2013-NZ$39.95 Million-23.2%
2012-NZ$52.02 Million19.68%
2011-NZ$43.46 Million133.81%
2010-NZ$18.59 Million68.22%
2009-NZ$11.05 Million-55.51%
2008-NZ$24.84 Million-45.62%
2007-NZ$45.67 Million255.63%
2006-NZ$12.85 Million198.18%
2005-NZ$4.31 Million-1.25%
2004-NZ$4.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-NZ$31.43 Million 559.60%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-NZ$0.28 Billion 5,693.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$14.27 B-299,603.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$28.42 B-596,599.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
NZ$13.90 B-291,937.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$15.75 B-330,710.78%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
NZ$16.13 B-338,799.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-NZ$21.42 Million 349.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.95 B-817,651.66%๐Ÿ‡บ๐Ÿ‡ธ USA